10 Cosmetic Ingredients Worth Knowing About: A Regulatory Shopping Guide
Summary
Ten cosmetic ingredients that have attracted significant regulatory attention — from EU bans to FDA proposed rules to IARC classifications. Here's what the evidence actually shows and what it means when you're reading a label.
10 Cosmetic Ingredients Worth Knowing About: A Regulatory Shopping Guide
Certain cosmetic ingredients have attracted formal regulatory attention — bans, restrictions, proposed rules, or mandatory safety reviews — in the EU, US, or other major markets. This guide covers ten that are genuinely worth understanding when you're reading a product label.
This is not a list of ingredients to panic about. Regulatory scrutiny ranges from precautionary restrictions in specific contexts to outright bans based on strong evidence. The nuance matters.
Note: This article provides consumer product information to support shopping decisions. It is not medical advice.
1. Long-Chain Parabens (Propylparaben, Butylparaben, Isobutylparaben, Isobutylparaben)
What they are: Synthetic preservatives used since the 1950s in nearly all water-containing cosmetics.
The evidence: Parabens bind to oestrogen receptors (in vitro; Routledge et al., 1998). Long-chain variants show the strongest oestrogenic activity. The EU SCCS completed updated safety assessments in 2024: methylparaben and ethylparaben are considered safe at permitted concentrations; propyl and butylparaben are restricted to ≤0.14% and banned in products for children under 3; isobutylparaben and isopropylparaben are banned outright from EU cosmetics.
On labels: Look for any ingredient ending in -paraben. Short-chain variants (methyl-, ethyl-) remain permitted.
2. Sodium Lauryl Sulfate (SLS)
What it is: An anionic surfactant; the primary lathering agent in most shampoos and body washes.
The evidence: SLS is a well-documented skin irritant at concentrations used in rinse-off products. It is used as a positive irritant control in clinical patch testing research — meaning it reliably causes mild measurable irritation under test conditions. The Cosmetic Ingredient Review (CIR) Expert Panel concluded SLS is safe for rinse-off use when formulated to avoid irritation; a 2002 study (Contact Dermatitis, Agner et al.) showed greater barrier disruption in atopic dermatitis patients vs. healthy controls.
What is not supported: Claims that SLS causes cancer or is systemically toxic at cosmetic use levels. Neither IARC, the EU SCCS, nor the CIR has classified SLS as carcinogenic.
On labels: INCI name Sodium Lauryl Sulfate. More relevant for those with eczema or sensitive skin.
3. Fragrance / Parfum
What it is: A single ingredient declaration that can legally represent a complex mixture of dozens or hundreds of individual chemical compounds, protected as a trade secret in the US and EU.
The evidence: Fragrance is the most common cause of allergic contact dermatitis in cosmetics. The EU requires individual disclosure of 26 specified allergens above threshold concentrations (Annex III, Regulation EC 1223/2009); from 2025, an expanded list of 56 allergens must be disclosed. Phthalates (including DEP) used as fragrance fixatives are not required to be individually listed in either the EU or US.
On labels: "Fragrance" (US) or "Parfum" (EU/INCI) appearing without individual component disclosure. "Fragrance-free" is the most meaningful claim for sensitive skin.
4. Formaldehyde-Releasing Preservatives
What they are: A class of preservatives that slowly release formaldehyde as they degrade, providing antimicrobial activity.
The evidence: Formaldehyde is classified by IARC as a Group 1 carcinogen (carcinogenic to humans), primarily based on evidence of nasopharyngeal cancer and leukaemia in occupational settings with high inhalation exposure. For topical cosmetic use, the EU Cosmetics Regulation restricts free formaldehyde in cosmetics to ≤0.2% (rinse-off) and ≤0.1% (leave-on), and requires mandatory "contains formaldehyde" warning labelling above 0.05%. California's AB 2491 (effective 2027) prohibits intentionally added formaldehyde in cosmetics.
On labels: DMDM Hydantoin, Quaternium-15, Imidazolidinyl Urea, Diazolidinyl Urea, Sodium Hydroxymethylglycinate, Bronopol.
5. Oxybenzone (Benzophenone-3)
What it is: A UV filter (both UVA and UVB) used in chemical sunscreens.
The evidence: A 2019 FDA-published pharmacokinetic study (JAMA) confirmed oxybenzone is absorbed through the skin and detectable in plasma at concentrations exceeding the FDA’s 0.5 ng/mL threshold for further safety review after one day of full-body application. US NHANES data found oxybenzone in urine of ~96% of Americans sampled. The FDA's proposed 2021 sunscreen rule does not classify oxybenzone as GRASE (Generally Recognized as Safe and Effective) and requests additional safety data. It has not been banned by the FDA.
EU status: Permitted at ≤6% in EU sunscreens; the EU SCCS reviewed oxybenzone and concluded the evidence of endocrine disruption at cosmetic exposure levels in adults is not established, though it called for more data on aggregate exposure.
On labels: INCI name Benzophenone-3. Mineral alternatives: zinc oxide (Zinc Oxide), titanium dioxide (Titanium Dioxide).
6. Retinyl Palmitate in Sunscreen
What it is: A cosmetic form of Vitamin A (retinoid) used as an antioxidant in some sunscreen formulations.
The evidence: The US National Toxicology Program (NTP) published animal studies suggesting retinyl palmitate may enhance UV-related skin tumour formation when used in sunscreens. The evidence is from animal studies under intense UV exposure; human data are lacking. The EU SCCS has reviewed retinyl palmitate and considers it safe at concentrations up to 0.3% in face products and up to 0.05% in body lotions when used with adequate UV protection. The FDA proposed limiting retinyl palmitate in sunscreens pending further data.
On labels: Retinyl Palmitate. Retinol (Retinol) in leave-on products used at night has a different and stronger evidence base for efficacy.
7. Triclosan
What it is: A synthetic broad-spectrum antimicrobial used in soaps, toothpaste, and deodorants.
The evidence: In 2016, the US FDA removed triclosan from consumer OTC antiseptic wash products (soaps, body washes), finding manufacturers had not demonstrated it was more effective than plain soap and water, while concerns about antibiotic resistance contribution and endocrine activity were unresolved. Canada banned triclosan in cosmetics in 2017. It remains permitted in the EU at ≤0.3% in specific product categories including toothpaste.
On labels: INCI name Triclosan. Related compound: Triclocarban (also removed from US OTC antiseptic washes in 2016).
8. Phthalates (DBP, DEHP, DIBP)
What they are: Synthetic plasticisers used as solvents and fixatives, particularly in nail products and fragrance formulations.
The evidence: DEHP, DBP, and DIBP are classified as reproductive toxicants under EU REACH and are banned in EU cosmetics (Annex II, Regulation EC 1223/2009). DBP is also banned in California cosmetics under the California Safe Cosmetics Act. The US FDA has no federal ban on phthalates in cosmetics; DEP (diethyl phthalate) remains permitted in US fragrance formulations.
On labels: DBP may appear as Dibutyl Phthalate in nail products. Most phthalate exposure in personal care comes through undisclosed fragrance components (see item 3). "Phthalate-free" on packaging is a verifiable claim.
9. Coal Tar Dyes
What they are: Synthetic dyes historically derived from coal tar, used in hair dyes and dandruff shampoos.
The evidence: Coal tar itself is classified by IARC as Group 1 carcinogenic to humans in occupational contexts (roofers, chimney sweeps). Specific coal tar-derived colours used in cosmetics have varying individual assessments; p-phenylenediamine (PPD), a common oxidative hair dye component, is a documented allergen. The EU does not permit coal tar as a cosmetic ingredient; specific dyes are individually assessed. The FDA permits certain coal tar dyes as colour additives in specific product categories with specific limits.
On labels: p-Phenylenediamine (p-Phenylenediamine or CI 76060); FD&C and D&C colour codes (US) indicate approved colour additives.
10. BHA (Butylated Hydroxyanisole)
What it is: A synthetic antioxidant used to prevent rancidity in cosmetics and food.
The evidence: BHA is classified by the EU as a Category 1 endocrine disruptor under the EU Endocrine Disruptor criteria, and is on the EU REACH candidate list as a substance of very high concern (SVHC). The IARC classifies BHA as Group 2B (possibly carcinogenic to humans) based on animal studies. The EU Scientific Committee has been reviewing its use in cosmetics; its use as a food additive (E320) is also under review. California's Proposition 65 lists BHA as a possible carcinogen; assembly bill AB 418 (2023) bans BHA as a food additive in California from 2027.
On labels: INCI name Butylated Hydroxyanisole or BHA. Related compound: BHT (Butylated Hydroxytoluene) — similar function, different regulatory assessment (not currently classified as an EDC at the same level as BHA).
Quick Reference Table
| Ingredient | EU Status | US FDA Status | Primary Concern |
|---|---|---|---|
| Long-chain parabens | Restricted / some banned | No restriction | Endocrine activity |
| SLS | Permitted (rinse-off) | Permitted | Skin irritation (dose-dependent) |
| Fragrance/Parfum | Allergen disclosure required | Trade secret; no disclosure | Contact allergy; hidden components |
| Formaldehyde releasers | Restricted; labelling required | Permitted; CA restricts from 2027 | IARC Group 1 carcinogen (formaldehyde) |
| Oxybenzone | Permitted ≤6% | Not GRASE; safety data requested | Systemic absorption; endocrine suspect |
| Retinyl palmitate | Permitted at limits | Safety data requested | Animal phototoxicity data |
| Triclosan | Restricted to specific uses ≤0.3% | Banned from OTC antiseptic washes | Antibiotic resistance; endocrine activity |
| Phthalates (DBP/DEHP) | Banned | No federal ban; CA restricts | Reproductive toxicant |
| Coal tar dyes | Individual approval only | Permitted in specific categories | Allergenicity; IARC Group 1 (coal tar) |
| BHA | EDC Category 1; under review | Permitted; CA food ban from 2027 | IARC Group 2B; endocrine disruptor |
ScoreKart identifies all of these ingredients by INCI name in scanned products and provides their current regulatory status for your market — so you can make an informed comparison before you buy.
Related Topics: